# A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension

> **NCT00751127** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 268 (actual)

## Conditions studied

- Glaucoma
- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** PhXA41
- **DRUG:** timolol

## Key facts

- **NCT ID:** NCT00751127
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-01
- **Primary completion:** 1994-02
- **Final completion:** 1994-02
- **Target enrollment:** 268 (ACTUAL)
- **Last updated:** 2011-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751127, "A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00751127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*